K.J. Harrison & Partners’s DexCom DXCM Stock Holding History

K.J. Harrison & Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,000	Closed	-$1.33M	–	238
2025 Q4	$1.33M	Buy	+20,000	New	+$1.29M	0.18%	124
2023 Q1	–	Sell	-3,000	Closed	-$460K	–	251
2022 Q4	$460K	Buy	+3,000	New	+$329K	0.09%	162
2022 Q2	–	Sell	-12,000	Closed	-$1.53M	–	263
2022 Q1	$1.53M	Sell	12,000 -4,000	-25%	-$438K	0.25%	105
2021 Q4	$2.15M	Buy	16,000 +4,000	+33%	+$575K	0.3%	103
2021 Q3	$1.65M	Hold	12,000	–	–	0.24%	119
2021 Q2	$1.28K	Hold	12,000	–	–	0.13%	139
2021 Q1	$1.08M	Hold	12,000	–	–	0.17%	144
2020 Q4	$1.11M	Buy	+12,000	New	+$1.07M	0.18%	150

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

K.J. Harrison & Partners's DXCM Position: Q1 2026 in Review

K.J. Harrison & Partners sold out of DexCom (DXCM) in Q1 2026, closing a stake of 20,000 shares — an estimated $1.33M sold.

K.J. Harrison & Partners first reported a position in DXCM in Q4 2020 and held it in 8 quarters. The position peaked at $2.15M in Q4 2021. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

K.J. Harrison & Partners reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
K.J. Harrison & Partners sold 20,000 DexCom shares in Q1 2026, an estimated $1.33M.
K.J. Harrison & Partners first reported a position in DexCom in Q4 2020 and held it in 8 quarters.
K.J. Harrison & Partners's DexCom position peaked at $2.15M in Q4 2021.
957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on K.J. Harrison & Partners's 13F filing for Q1 2026, filed 28 Apr 2026.